Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × osimertinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 8 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage II-IIIB Non-small Cell Lung Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡